Rankings
▼
Calendar
IMA
ImageneBio Inc
$69M
Q1 2020 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$3M
Gross Profit
-$5M
-144.6% margin
Operating Income
-$7M
-222.4% margin
Net Income
-$7M
-215.2% margin
EPS (Diluted)
$-0.50
QoQ Revenue Growth
+15.1%
Cash Flow
Operating Cash Flow
-$10M
Free Cash Flow
-$10M
Stock-Based Comp.
$375,000
Balance Sheet
Total Assets
$0
Total Liabilities
$0
Stockholders' Equity
$17M
Cash & Equivalents
-$82M
← FY 2020
All Quarters
Q2 2020 →
IMA Q1 2020 Earnings — ImageneBio Inc Revenue & Financial Results | Market Cap Arena
